GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Flowr Corp (TSXV:FLWR.H) » Definitions » YoY EBITDA Growth

The Flowr (TSXV:FLWR.H) YoY EBITDA Growth : 50.00% (As of Sep. 2022)


View and export this data going back to 2017. Start your Free Trial

What is The Flowr YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. The Flowr's YoY EBITDA Growth for the quarter that ended in Sep. 2022 was 50.00%.

The Flowr's EBITDA per Share for the three months ended in Sep. 2022 was C$-0.01.


The Flowr YoY EBITDA Growth Historical Data

The historical data trend for The Flowr's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Flowr YoY EBITDA Growth Chart

The Flowr Annual Data
Trend Jun17 Jun18 Dec19 Dec20 Dec21
YoY EBITDA Growth
- -7,423.08 65.75 -177.61 77.74

The Flowr Quarterly Data
Sep17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.48 73.38 21.43 -1,300.00 50.00

The Flowr YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

The Flowr's YoY EBITDA Growth for the fiscal year that ended in Dec. 2021 is calculated as:

YoY EBITDA Growth (A: Dec. 2021 )
=(EBITDA per Share (A: Dec. 2021 )-EBITDA per Share (A: Dec. 2020 ))/ | EBITDA per Share (A: Dec. 2020 ) |
=(-0.207--0.93)/ | -0.93 |
=77.74 %

The Flowr's YoY EBITDA Growth for the quarter that ended in Sep. 2022 is calculated as:

YoY EBITDA Growth (Q: Sep. 2022 )
=(EBITDA per Share (Q: Sep. 2022 )-EBITDA per Share (Q: Sep. 2021 )) / | EBITDA per Share (Q: Sep. 2021 )) |
=(-0.005--0.01)/ | -0.01 |
=50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Flowr YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of The Flowr's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


The Flowr (TSXV:FLWR.H) Business Description

Traded in Other Exchanges
N/A
Address
9590 McCarthy Road, Kelowna, BC, CAN, V4V 1R2
The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.

The Flowr (TSXV:FLWR.H) Headlines

No Headlines